On the other hand, treatments with the ER-β selective agonist, WAY-202196, exert a protective effect in both male and female rodents subjected to CLP by decreasing TNF-α and IL-6 levels, reducing bacteremia, and maintaining intestinal integrity [227]. Here, TNF is linked to bacterial infectious disease with sepsis.